ARTICLE | Company News
Carmot, Sunesis deal
February 15, 2010 8:00 AM UTC
Carmot received an exclusive license to Sunesis' Chemotype Evolution fragment-based lead discovery technology. Carmot will use the technology to identify compounds to treat inflammatory, metabolic, an...